New lupus drug E6742 enters Mid-Stage trial

NCT ID NCT07515014

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether the experimental drug E6742 can reduce lupus disease activity better than a placebo. About 256 adults with lupus will take either E6742 or a placebo pill for 24 weeks. The main goal is to see if more people on E6742 achieve a meaningful reduction in symptoms while using a low dose of steroids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
E6742
What this could lead to
If successful, this could point toward a new treatment option for lupus that helps control disease activity while allowing lower steroid doses.
What could go wrong
This is an early phase 2 trial with only 256 participants, so results may not apply to all lupus patients. The drug may not work better than placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chang Gung Memorial Hospital, Linkou

    NOT_YET_RECRUITING

    Taoyuan, Taiwan

  • Chonnam National University Hospital

    NOT_YET_RECRUITING

    Gwangju, South Korea

  • Daido Clinic

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Dokkyo Medical University Hospital

    NOT_YET_RECRUITING

    Mibu-Machi, Shimotsugagun, Tochigi, Japan

  • First Hospital of Shanxi Medical University

    NOT_YET_RECRUITING

    Taiyuan, Shanxi, China

  • Fujita Health University Hospital

    RECRUITING

    Toyoake, Aichi-ken, Japan

  • Hiroshima Prefectural Hospital

    RECRUITING

    Hiroshima, Japan

  • Hokkaido University Hospital

    RECRUITING

    Sapporo, Hokkaidô, Japan

  • Hyogo Medical University Hospital

    RECRUITING

    Nishinomiya, Hyōgo, Japan

  • Japan Community Health Care Organization (JCHO) Chukyo Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Japan Institute for Health Security National Center for Global Health and Medicine

    RECRUITING

    Shinjuku, Tokyo, Japan

  • Jilin Province People's Hospital

    NOT_YET_RECRUITING

    Changchun, Jilin, China

  • Jiujiang No.1 People's Hospital

    NOT_YET_RECRUITING

    Jiujiang, Jiangxi, China

  • Juntendo University Hospital

    RECRUITING

    Bunkyo, Tokyo, Japan

  • Kaohsiung Veterans General Hospital

    RECRUITING

    Kaohsiung City, Taiwan

  • Kobe University Hospital

    RECRUITING

    Kobe, Hyôgo, Japan

  • Kumamoto Shinto General Hospital

    RECRUITING

    Kumamoto, Japan

  • Nanfang Hospital Southern Medical University - PPDS

    RECRUITING

    Guangzhou, Guangdong, China

  • Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School-Main

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, China

  • National Hospital Organization Kyushu Medical Center

    RECRUITING

    Fukuoka, Japan

  • Niigata University Medical and Dental Hospital

    RECRUITING

    Niigata, Japan

  • Peking Union Medical College Hospital - East Campus

    RECRUITING

    Beijing, Beijing Municipality, China

  • Pingxiang People's Hospital

    RECRUITING

    Pingxiang, Jiangxi, China

  • Shanxi Bethune Hospital

    NOT_YET_RECRUITING

    Taiyuan, Shanxi, China

  • Shinkenko Clinic

    RECRUITING

    Naha, Okinawa, Japan

  • Taipei Veterans General Hospital

    NOT_YET_RECRUITING

    Taipei, Taiwan

  • The Affiliated Hospital of Guizhou Medical University

    RECRUITING

    Guiyang, Guizhou, China

  • The First Affiliated Hospital of Bengbu Medical University

    NOT_YET_RECRUITING

    Bengbu, Anhui, China

  • The First Affiliated Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, China

  • The First Affiliated Hospital of Nanchang University - Donghu Campus

    RECRUITING

    Nanchang, Jiangxi, China

  • The First Affiliated Hospital of Shantou University Medical College

    RECRUITING

    Shantou, Guangdong, China

  • The First Affiliated Hospital of Soochow University - Pinghailu Campus

    NOT_YET_RECRUITING

    Suzhou, Jiangsu, China

  • The Second Affiliated Hospital of Soochow University

    RECRUITING

    Suzhou, Jiangsu, China

  • The Second Affiliated Hospital, Zhejiang University School of Medicine - Jiefanglu Campus

    RECRUITING

    Hangzhou, Zhejiang, China

  • The Second Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, China

  • The Third Affiliated Hospital, Sun Yat-Sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • Toho University Omori Medical Center

    RECRUITING

    Ōta-ku, Tokyo, Japan

  • Tohoku Medical and Pharmaceutical University Hospital

    RECRUITING

    Sendai, Miyagi, Japan

  • Tokyo Metropolitan Tama Medical Center

    RECRUITING

    Fuchū, Tokyo, Japan

  • University of Occupational and Environmental Health University Hospital

    RECRUITING

    Kitakyushu, Fukuoka, Japan

  • Yichang Central People's Hospital - Xiling Campus

    NOT_YET_RECRUITING

    Yichang, Hubei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.